Klotho Neurosciences Inc (KLTO) Cotización

It shows for a worthless company.

Seems they’ve paid someone in stock issuing a $1.2mm note OID -20% and gave the same investor 2,000,000 shares of stock to buy the note. The note is convertible at $0.25 per share. In other words, they sold shares for $0.12. Who is running the BOD?

klto monster

klto running

klto running

Leas was a Scam and wena,Klto the same.Scam.

Get this trash delisted already!!! It's been trading under $1 for well over 10 days!!! Get it together SEC and do your job! 

Friday was interesting. Will it continue to show volume today?
Break $0,80 and I think we hit $1.00 this week.
Hmmmmm….

Year chart might be showing a nice flag formation.
I might grab some today if we get to $0,65.
I will buy more at $0.70.
Enjoy

Pump and dump?
Lull before the storm?
Watching but not excited about the trading.
If it moves back to $0.70 then I might buy a few.

Cofounder of Shire and cofounder of Moderna involved… why?
Looks like a small cap biotech with some interesting trading today.
Closely watching this play.

Can we change name of this Board to KLTO? or merge them

The Board of ANEW MEDICAL, INC. (NASDAQ: WENA), today announced a name and ticker symbol change to Klotho Neurosciences, Inc. (NASDAQ: KLTO), and has launched a new website, www.klothoneuro.com. The name and ticker change will have no impact on current shareholders, and there is no action required on their part.
The new name embodies the Company's commitment to strategically direct its core investments of time and financial resources toward the multibillion-dollar market opportunities for the company’s patented Klotho gene technology assets in the neurosciences sector. Through its exclusive worldwide license, the company’s patent protected secreted form of the Klotho gene, s-KL, provides Klotho Neurosciences with the opportunity to invest its strategic resources into two distinct major market segments.

More like .75 and then lower by the day! Trash!!

Love watching this POS FAIL!! Get this delisted and lock up the Doc!!!

WENA new 52 week low

Pulling a nice Oscar Meyer WENA move up .. 06:05 AM EDT, 08/21/2024 (MT Newswires) -- Anew Medical (WENA) said Wednesday it signed an exclusive worldwide license agreement with Transfertech Sherbrooke for Nanoject.

Financial terms were not disclosed.

Nanoject is a needle-free, freeze-dried nanopowder autoinjector for medicines and vaccines.

Shares of the company jumped over 48% in recent premarket activity Wednesday.

yup. I'll buy this turd when it's at a penny or less. Losers.

Piece of Shit Scummer stinky Doc 💩💩

WENA.......................https://stockcharts.com/h-sc/ui?s=WENA&p=W&b=5&g=0&id=p86431144783

WENA........................https://stockcharts.com/h-sc/ui?s=WENAp=W&b=5&g=0&id=p86431144783

Loaded ready to go!!!

Liftoff $1.75pps coming

yup could blow up

ZERO BORROW on this low floater,could get interesting

WENA under $2

Doctor Stink 💩

hopped back in today.

Weeeeeee

Just picked up Few. This is Priming. I’ll buy more once Break Happens

This one Almost Ready! Looking for a $1.80 Break and I’m in!

Got a Runner.

W YORK, July 09, 2024 (GLOBE NEWSWIRE) -- ANEW MEDICAL, INC. (NASDAQ: WENA) (“ANEW”), a biopharmaceutical company specializing in the advancement of novel disease-modifying therapies for neurological and age-related disorders, announces plans to advance its recently patented Klotho gene therapy program for neurodegenerative disorders.

ANEW has compelling initial data suggesting that maintaining elevated levels of Klotho in the body significantly contributes to longer, healthier lifespans. Conversely, the data reveals that individuals with depleted or lower-than-normal levels of Klotho are more susceptible to neurodegenerative disorders such as ALS, Alzheimer’s, and Parkinson’s Disease. ANEW will also investigate other age-related disorders associated with depleted Klotho levels, such as memory loss, osteoporosis, sarcopenia (muscle wasting), diabetes mellitus, and certain cardiovascular conditions.

Dr. Joseph Sinkule, CEO and Founder of ANEW MEDICAL, commented: “Administering a medication based on the Klotho isoform of interest, secreted Klotho (s-KL), may contribute to longer, healthier lives. Research by our strategic partner, the Okinawa Research Center for Longevity Science (ORCLS) in Japan, suggests that the Klotho gene is a key factor in age-related longevity. Klotho emerged as one of the two most significant genes from their studies, and we look forward to continuing our research with ORCLS as we advance ANEW’s clinical development programs for Neurodegenerative Disorders.”

ANEW has development plans to advance its program in three distinct areas:

FDA Clinical Trials: The development of therapeutics to treat neurodegenerative diseases and age-related disorders involves using an adenovirus (AAV) vector to deliver the secreted Klotho gene DNA sequence to neurons in the central nervous system (CNS). This approach aims to correct deficiencies in the levels of s-KL.
$2.18 + 50% Klotho Diagnostics: The development and commercialization of a diagnostic that will enable healthcare providers to accurately quantify levels of Klotho gene and protein isoforms in blood samples. This tool will also provide ANEW with the necessary diagnostic to screen patients for its clinical trials.
Age-Related Disorders: ANEW plans to develop exploratory approaches to promote longevity in healthy populations using gene or cell-based Klotho therapies, as well as other genes of interest that are directly related to longevity.
Dr. Shalom Hirshman, M.D., Chief Medical Advisor and Board member, stated: “ANEW is in a strong position to significantly influence the treatment of ALS, Alzheimer’s, and other neurodegenerative disorders. With our patent-protected gene therapy platform technology, we have the potential to improve health and extend life expectancy.”

$LEAS $RWOD $WENA Criminality is criminality, plain and simple. This company was built on the backs of innocent investors like myself and many others who had their investments in the sister company, $LEAS, fraudulently wiped out by a rogue Doctor, Joseph Sinkule, and his accomplices. They stole 99% of our hard-earned resources, leaving us with almost nothing. But they underestimated us - We wont just cry and walk away. I personally will follow this stock to its ultimate demise, its grave. Please Join the class action lawsuit folks…

Warning: $WENA, $LEAS, and $RWOD are complete scams! They have defrauded innocent investors and I urge you to exercise extreme caution. Do not put your money into $WENA or related companies being managed by especially Dr. Joseph Sinkule aka Dr. Sink-Hole. These scammers will stop at nothing to deceive and exploit vulnerable investors. Beware of fraud!!!

WENA.........................https://stockcharts.com/h-sc/ui?s=WENA&p=W&b=5&g=0&id=p86431144783

WENA COVER BOTTOM PLAY

wena is rising :o)

Still just holding my limp WENA...

grabbed some.

I guess the folks who bought that stock right before the merger hired the computer wash traders to help them dump it in.

Don't get trapped... this isn't real.

thought there was only 5000000 shares hmmm :o)

Buying here. Slow walk down

and I’m out, taking profits is what’s been my secret, and kept me in the game. GL

I bought some shares about 30 minutes ago. Thats what caused the down turn. Sorry. I kill stocks every time I buy.

WENAW (Warrants): That's what I grabbed --- hope we all get a big, fat, 10-bagger today!!

As mentioned yesterday - anyone short is going to get squeezed to death -

...granted and issued a patent in Europe, EP3377091B1, for the use of ANEW’s secreted Klotho gene sequence and gene delivery systems to be used in the treatment of diminished cognition, memory loss, dementia and other neurodegenerative diseases.

Nice news. No stocktwits or yahoo board.

...and now we are left holding our WENAs.